Though prominent yet variable Gal-9 expression was observed in both TME epithelial and stromal cells within cytosolic or nuclear compartments, Gal-9 stromal staining was preferentially observed in TN and human epidermal growth factor receptor 2 (HER2) breast cancer subtypes [155]. This evidence concerns the gene LGALS9 and breast carcinoma.